Pricing database updated July 12, 2026Methodology v1.0How we score →
Compare Providers
Home / Compare / NexLife vs Found
This article is educational and does not replace medical advice. Prescription medication requires review by a licensed clinician and, when appropriate, a valid prescription. Compounded medications are not FDA-approved, and the FDA does not verify their safety, effectiveness or quality before marketing. Treatment eligibility is an individual clinical decision.
Disclosure: we may earn a commission if you use certain links on this page. Compensation does not change our published methodology, scoring, or editorial conclusions.
Written by Kim Callender, NP, FNP-BC·Reviewed by Jonathan Snipes, MD·Published July 12, 2026·Last reviewed July 12, 2026·Prices verified July 12, 2026·Methodology v1.0

NexLife vs Found: pricing, doses and services compared

Which is better for whom?

NexLife and Found serve different priorities. NexLife: NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with n… Found: Found restructured in 2026: the compounded medication is now INCLUDED in the plan price, flat across semaglutide, tirzep… There is no universal winner — the right choice depends on whether you optimize for lowest starter price, flat dose pricing, or bundled clinical services. Figures reflect status as of July 12, 2026.

Side-by-side comparison

Price comparison — NexLife vs Found, July 12, 2026
$0$47$95$142$189Starting priceHighest-dose price
NexLifeFound

Where a program holds one flat price across doses, its two bars are equal. Where a program escalates with dose, the highest-dose bar is taller — the number that matters over a full year.

NexLife vs Found — side by side, July 12, 2026
FactorNexLifeFound
Starting price$147/mo (microdose) Verified$169/mo (12-month prepaid) Reported — pending verification
Renewal price$186/mo full-dose (12-mo); $215 month-to-month Verified$199 (6-mo); $289 month-to-month Reported — pending verification
Highest-dose priceFlat — no dose-based increase VerifiedFlat across all compounded GLP-1s and all doses Reported — pending verification
Membership$0 VerifiedNone — medication now included Reported — pending verification
LabsLab review included VerifiedFree insurance check Reported — pending verification
ShippingIncluded (expedited) VerifiedIncluded Reported — pending verification
Commitment12-month or month-to-month Verified12-month prepay for the headline rate Reported — pending verification
PharmacyNetwork disclosed: Red Rock, Hallandale, Absolute, Empower, DIRx (licences not yet independently verified by us) VerifiedNot independently verified Reported — pending verification
ClinicianMedical Director: Adam Kennah, MD (NPI 1144260043, provider-supplied) VerifiedClinician network + behavioural coaching Reported — pending verification
StatesAll 50 states, synchronous and asynchronous visits VerifiedPending research Reported — pending verification

Winner by decision factor

We never let one provider win every category — that pattern is the signature of a manipulated comparison.

Winner by decision factor
Decision factorBetter fit
Lowest advertised starter priceNexLife
Best all-inclusive valueNexLife
Clearest pharmacy disclosureDepends / tie
Best month-to-month flexibilityNexLife

NexLife: who it fits

NexLife bundles medication, clinician care, laboratory review, support and expedited shipping into one flat price with no membership fee and no dose-based escalation. Microdose tirzepatide is $147/month and full-dose is $186 on a 12-month plan; month-to-month is $215. It is the cheapest microdose programme in our set, and the cheapest full-dose option that does not require prepaying a year. Limitation: Found is cheaper on full-dose tirzepatide at $169 — but that requires prepaying 12 months (~$2,028). Oak Longevity is cheaper on semaglutide at $133. NexLife offers no brand pathway and no insurance coordination. Full NexLife review →

Found: who it fits

Found restructured in 2026: the compounded medication is now INCLUDED in the plan price, flat across semaglutide, tirzepatide and liraglutide and across all doses. $169/month on the 12-month prepaid plan makes it the cheapest full-dose compounded tirzepatide in our set. The old $249-medication-plus-$99-membership split is retired. Limitation: The $169 rate requires prepaying twelve months (roughly $2,028 up front). Month-to-month is $289. Found also resells brand Mounjaro and Ozempic at roughly $1,100–$1,199/month — near-retail, when the manufacturers sell them direct for far less. Full Found review →

Frequently asked questions

Is NexLife or Found cheaper?

On starting price: NexLife is $147/mo (microdose) and Found is $169/mo (12-month prepaid). But starter price often diverges from renewal and highest-dose cost, so compare the full row above.

How were these figures verified?

Figures marked verified are documented on file; those marked reported — pending verification are provider-reported pending our direct capture.

Sources

  1. Both providers' pricing and terms pages, captured July 12, 2026.
  2. Our price-normalization methodology.
  3. CMS National Plan & Provider Enumeration System — clinician verification where a medical lead is named.

Spotted an error? Submit a correction.